Story thread · 7 reports / 5 sources
AbCellera (ABCL) Stock Jumps 41% After Hot Flash Drug Trial Success
bloomberg.com · 1d
How the coverage leans
Across 5 sources · syndicated copies counted once
Biotech company AbCellera Biologics Inc. jumped as much as 41%, giving it a market value of almost $3 billion, after it said a potential remedy for hot flashes was effective in a mid-stage trial.
First report: AbCellera to Announce Top-Line Results from the Phase 2 Trial of ABCL635 for the Treatment of Moderate-to-Severe VMS Due to Menopause on Monday, August 10, 2026 — financialpost.com, 4d
The coverage
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.